(¿Â¶óÀÎ) 2021³â Á¦33ȸ ´ëÇÑ°£ÇÐȸ Ãá°è ¿Â¶óÀÎ Single Topic Symposium : 2021-03-20±³À°ÀÏÀÚ : 2021-03-20
±³À°Àå¼Ò : ¿Â¶óÀÎ ±³À°
±³À°ÁÖÁ¦ :
(¿Â¶óÀÎ) 2021³â Á¦33ȸ ´ëÇÑ°£ÇÐȸ Ãá°è ¿Â¶óÀÎ Single Topic Symposium ÁÖÃÖ±â°ü : ´ëÇÑ°£ÇÐȸ
´ã´çÀÚ : ´ëÇÑ°£ÇÐȸ Áغñ»ç¹«±¹
¿¬¶ôó : 02-373-1005
À̸ÞÀÏ :
kaslsecretariat@hbni.co.kr ±³À°Á¾·ù : ³»°ú
Âü¼®¿¹»óÀοø : 200¸í
Èñ¸ÁÆòÁ¡ : 3Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 3 ½Ã°£ 0ºÐ
¼¼ºÎ¼ö°·á : 40,000¿ø
ºñ°í ȸ¿ø, ÀüÀÓÀÇ, Àü°øÀÇ 30,000¿ø ºñȸ¿ø, ¿Â¶óÀΠȸ¿ø 40,000¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 03¿ù 20ÀÏ ¿Â¶óÀÎ °³ÃÖ 13:40~14:00 Adipose-Liver Axis in Liver Disease ¹é¾çÇö(µ¿¾ÆÀÇ´ë)
±³À°½Ã°£ 03¿ù 20ÀÏ ¿Â¶óÀÎ °³ÃÖ 14:00~14:20 Gut-Liver Axis in Liver Disease À¯¼öÁ¾(¼¿ïÀÇ´ë)
±³À°½Ã°£ 03¿ù 20ÀÏ ¿Â¶óÀÎ °³ÃÖ 14:20~14:40 Enteroendocrine Hormone in Liver Disease Á¶À¯¸®(Â÷ÀÇ°ú´ë)
±³À°½Ã°£ 03¿ù 20ÀÏ ¿Â¶óÀÎ °³ÃÖ 14:50~15:10 How to Screen and Assess Nutrition Status in Liver Disease À¯Á¤È¯(ÀÎÇÏÀÇ´ë)
±³À°½Ã°£ 03¿ù 20ÀÏ ¿Â¶óÀÎ °³ÃÖ 15:10~15:30 Sarcopenia in Liver Disease: How to Assess and Its Clinical Implication È«¿µ¹Ì(ºÎ»êÀÇ´ë)
±³À°½Ã°£ 03¿ù 20ÀÏ ¿Â¶óÀÎ °³ÃÖ 15:30~15:50 Macro- and Micro- Nutrients in Liver Disease: Clinical Meaning and Strategy for Supplement À̹ÎÁ¾(ÀÌÈÀÇ´ë)
±³À°½Ã°£ 03¿ù 20ÀÏ ¿Â¶óÀÎ °³ÃÖ 16:00~16:20 Patients with Sarcopenic Liver Disease ¼±¤ÀÏ(°í½ÅÀÇ´ë)
±³À°½Ã°£ 03¿ù 20ÀÏ ¿Â¶óÀÎ °³ÃÖ 16:20~16:40 Patients with Liver Failure and/or Receiving Resection/Liver Transplantation Çã³»À±(ÀÎÁ¦ÀÇ´ë)
±³À°½Ã°£ 03¿ù 20ÀÏ ¿Â¶óÀÎ °³ÃÖ 16:40~17:00 Patients with Variceal Bleeding and/or Hepatic Encephalopathy ÀÓ¼±¿µ(°í·ÁÀÇ´ë)